Advertisement
Screener

Mirum Pharmaceuticals, Inc. (MIRM) Graph

MIRM Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2018-06-30: Net income -$10.00K.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

MIRM revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$176.24MBile Acid Medicines$47.52MLivmarli$128.72MRevenue$176.24MOperating expenses$218.78MOperating income-$42.54MOther income, net-$24.23MSelling, general& administrative$81.47MPre-tax income-$65.54MIncome tax$1.69MNet income-$67.23M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 2 month

Period endNet income
2018-06-30-$10.00K

Revenue and expense 3 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$176.24M(m)$81.47M$218.78M$1.69M-$67.23M
2026-03-31$159.88M(m)$96.33M$949.35M$475.00K-$790.15M
2025-12-31$148.93M*(m)$74.13M*$153.50M*$767.00K*-$5.73M*
2025-09-30$133.01M(m)$61.91M$130.41M-$262.00K$2.90M
2025-06-30$127.78M(m)$63.29M$132.77M$402.00K-$5.86M
2025-03-31$111.58M(m)$57.71M$126.77M$1.03M-$14.68M
2024-09-30$90.38M(m)$50.55M$103.06M$347.00K-$14.23M
2024-06-30$77.88M(m)$49.21M$102.11M$635.00K-$24.64M
2024-03-31$69.22M(m)$45.64M$95.69M$624.00K-$25.28M
2023-09-30$47.73M(m)$36.53M$72.87M$249.00K-$23.59M
2023-06-30$37.50M(m)$32.95M$61.77M$316.00K-$74.04M
2023-03-31$31.60M(m)$30.22M$58.75M$201.00K-$30.13M
2022-09-30$18.78M(m)$22.51M$51.66M$13.00K-$35.71M
2022-06-30$17.48M(m)$20.97M$48.92M-$6.57M-$26.92M
2022-03-31$12.89M(m)$19.12M$45.63M$11.00K-$36.61M
2021-09-30$5.00M(m)$17.35M$47.82M$9.00K-$47.11M
2021-06-30$11.00M(m)$13.35M$48.40M$11.00K-$43.89M
2021-03-31$0.00(m)$9.48M$47.61M$5.00K-$50.53M
2020-09-30$0.00(m)(m)$21.72M-$3.00K-$21.51M
2020-06-30$0.00(m)(m)$23.60M$3.00K-$23.25M
2020-03-31(m)(m)(m)$22.03M$4.00K-$21.31M
2019-09-30(m)$12.16M(m)$15.87M$0.00-$15.09M
2019-06-30(m)$11.59M(m)$14.03M$0.00-$13.56M
2019-03-31(m)(m)(m)$6.18M$0.00-$5.96M
2018-09-30(m)$3.00K(m)$65.00K$0.00-$67.00K
2018-06-30(m)(m)(m)(m)$0.00(m)

Revenue and expense 5 month

Period endResearch and developmentOperating expensesIncome taxNet income
2018-09-30$3.00K$75.00K$0.00-$77.00K

Revenue and expense 6 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$336.13M(m)$177.80M$1.17B$2.16M-$857.38M
2025-06-30$239.37M(m)$120.99M$259.54M$1.43M-$20.54M
2024-06-30$147.10M(m)$94.85M$197.80M$1.26M-$49.92M
2023-06-30$69.09M(m)$63.17M$120.52M$517.00K-$104.17M
2022-06-30$30.38M(m)$40.09M$94.55M-$6.56M-$63.53M
2021-06-30$11.00M(m)$22.83M$96.01M$16.00K-$94.43M
2020-06-30$0.00(m)(m)$45.63M$7.00K-$44.56M
2019-06-30(m)$16.45M(m)$20.22M$0.00-$19.51M
2018-06-30(m)(m)(m)(m)$0.00(m)

Revenue and expense 8 month

Period endOperating expensesIncome taxNet income
2018-12-31$17.41M$0.00(m)

Revenue and expense 9 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$372.38M(m)$182.90M$389.95M$1.17M-$17.63M
2024-09-30$237.47M(m)$145.39M$300.86M$1.61M-$64.15M
2023-09-30$116.82M(m)$99.70M$193.39M$766.00K-$127.76M
2022-09-30$49.16M(m)$62.60M$146.22M-$6.55M-$99.23M
2021-09-30$16.00M(m)$40.19M$143.84M$25.00K-$141.53M
2020-09-30$0.00(m)(m)$67.34M$4.00K-$66.07M
2019-09-30(m)$28.61M(m)$36.09M$0.00-$34.60M

Revenue and expense 12 month

Period endRevenueSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$521.31M$257.03M$543.45M$1.94M-$23.36M
2024-12-31$336.89M$202.22M$424.49M$1.03M-$87.94M
2023-12-31$186.37M$145.88M$295.53M$991.00K-$163.41M
2022-12-31$77.06M$89.07M$208.28M-$6.41M-$135.66M
2021-12-31$19.14M$59.22M$192.55M$37.00K-$83.99M
2020-12-31$0.00(m)$104.30M$6.00K-$103.27M
2019-12-31(m)(m)$54.74M$21.00K-$52.55M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Liquidia Corp (LQDA)United States$6.347B51.23
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Veradermics, Inc (MANE)United States$4.839B